Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of ampicillin/sulbactam and amoxicillin/clavulanic acid during haemodialysis
2012-001496-36Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ampicillin + sulbactam and amoxicillin + clavulanate in bacterial disease and acute bronchitis (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Pharmacokinetics of ampicillin/sulbactam and amoxicillin/clavulanic acid in haemodialysis. Started Jun 2013; status: completed.
02
Drugs
ampicillin + sulbactamamoxicillin + clavulanate
03
Conditions
bacterial diseaseacute bronchitis
Beyond the preview
Go deeper on 2012-001496-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001496-36.